Wachter Eric Phd

Wachter Eric Phd is listed in filings as CTO at Provectus Biopharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Dec 4, 2024, including 1 public disclosure. Recent filings connect the profile to Provectus Biopharmaceuticals, Inc. (PVCT). The current snapshot covers public activity from Dec 4, 2024. Reported amounts are shown as $612.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.